Japanese conglomerate Kaneka Corp.

Japanese conglomerate Kaneka Corp. has inked an agreement to buy Israeli startup Endostream Medical, a medical device developer for the treatment of brain aneurysms, in a deal valued at about $100 million.  Following the acquisition, the operations of the Or Akiva-based medical device startup will remain in Israel and serve as Kaneka’s research & development center. Kaneka plans to keep Endostream’s 12 employees and hire additional staff to jointly develop devices for the treatment of cerebrovascular diseases that affect the blood flow to the brain, such as aneurysms and strokes.